CoChat

USP7 - a crucial regulator of cancer hallmarks

Saha, Gouranga, Roy, Srija, Basu, Malini, Ghosh, Mrinal K. · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Cited by 101

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Over the course of three decades of study, the deubiquitinase Herpesvirus associated Ubiquitin-Specific Protease/Ubiquitin-Specific Protease 7 (HAUSP/USP7) has gradually come to be recognized as a crucially important molecule in cellular physiology. The fact that USP7 is overexpressed in a number of cancers, including breast, prostate, colorectal, and lung cancers, supports the idea that USP7 is also an important regulator of tumorigenesis. In this review, we discuss USP7's function in relation to the cancer hallmarks described by Hanahan and Weinberg. This post-translational modifier can support increased proliferation, block unfavorable growth signals, stop cell death, and support an unstable cellular genome by manipulating key players in the pertinent signalling circuit. It is interesting to note that USP7 also aids in the stabilization of molecules that support angiogenesis and metastasis. Targeting USP7 has now emerged as a crucial component of USP7 research because pharmacological inhibition of USP7 supports p53-mediated cell cycle arrest and apoptosis. Efficacious USP7 inhibition is currently being investigated in both synthetic and natural compounds, but issues with selectivity and a lack of co-crystal structure have hindered USP7 inhibition from being tested in clinical settings. Moreover, the development of new, more effective USP7 inhibitors and their encouraging implications by numerous groups give us a glimmer of hope for USP7-targeting medications as effective substitutes for hazardous cancer chemotherapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbcan.2023.188903

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 187

  1. Hanahan, 2000, The hallmarks of cancer, Cell., 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  2. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell., 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  3. van der Knaap, 2005, GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7, Mol. Cell, 17, 695, 10.1016/j.molcel.2005.02.013 · DOI · Paper page
  4. Lu, 2021, Targeting ubiquitin-specific protease 7 (USP7) in cancer: a new insight to overcome drug resistance, Front. Pharmacol., 12
  5. Yeasmin Khusbu, 2018, Targeting ubiquitin specific protease 7 in cancer: a deubiquitinase with great prospects, Cell Biochem. Funct., 36, 244, 10.1002/cbf.3336 · DOI · Paper page
  6. Faesen, 2011, Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase, Mol. Cell, 44, 147, 10.1016/j.molcel.2011.06.034 · DOI · Paper page
  7. Su, 2018, Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis, J. Clin. Invest., 128, 4280, 10.1172/JCI120518 · DOI · Paper page
  8. Cilloni, 2012, Molecular pathways: BCR-ABL, Clin. Cancer Res., 18, 930, 10.1158/1078-0432.CCR-10-1613 · DOI · Paper page
  9. Elias, 2014, BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-frequency and clinical outcome, Leuk. Res., 38, 454, 10.1016/j.leukres.2013.12.025 · DOI
  10. Morotti, 2015, HAUSP compartmentalization in chronic myeloid leukemia, Eur. J. Haematol., 94, 318, 10.1111/ejh.12422 · DOI
  11. Morotti, 2014, BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP, Leukemia., 28, 1326, 10.1038/leu.2013.370 · DOI
  12. Shibata, 2020, Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells, Oncogene., 39, 3867, 10.1038/s41388-020-1253-0 · DOI
  13. Huang, 2017, Oridonin triggers chaperon-mediated proteasomal degradation of BCR-ABL in Leukemia, Sci. Rep., 7, 41525, 10.1038/srep41525 · DOI · Paper page
  14. Yoshihara, 2012, Insulin/insulin-like growth factor (IGF) stimulation abrogates an association between a deubiquitinating enzyme USP7 and insulin receptor substrates (IRSs) followed by proteasomal degradation of IRSs, Biochem. Biophys. Res. Commun., 423, 122, 10.1016/j.bbrc.2012.05.093 · DOI
  15. Jones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3
  16. Chen, 2015, The deubiquitinating enzyme USP7 regulates androgen receptor activity by modulating its binding to chromatin, J. Biol. Chem., 290, 21713, 10.1074/jbc.M114.628255 · DOI
  17. Pluciennik, 2021, Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy, J. Clin. Invest., 131, 10.1172/JCI134565 · DOI
  18. Cartel, 2021, Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy, Leukemia., 35, 417, 10.1038/s41375-020-0878-x · DOI
  19. Zhang, 2014, ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1, Nat. Cell Biol., 16, 864, 10.1038/ncb3013 · DOI · Paper page
  20. Bassermann, 2008, The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint, Cell., 134, 256, 10.1016/j.cell.2008.05.043 · DOI · Paper page
  21. Shin, 2020, Combination of inhibitors of USP7 and PLK1 has a strong synergism against paclitaxel resistance, Int. J. Mol. Sci., 21, E8629, 10.3390/ijms21228629 · DOI
  22. Yim, 2017, Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity, Oncogene., 36, 966, 10.1038/onc.2016.263 · DOI
  23. Oh, 2007, Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity, Biochem. Biophys. Res. Commun., 357, 615, 10.1016/j.bbrc.2007.03.193 · DOI
  24. Georges, 2019, USP7 regulates cytokinesis through FBXO38 and KIF20B, Sci. Rep., 9, 2724, 10.1038/s41598-019-39368-y · DOI
  25. Ying, 2006, Targeting retinoblastoma protein for degradation by proteasomes, Cell Cycle, 5, 506, 10.4161/cc.5.5.2515 · DOI
  26. Delston, 2011, p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis, Oncogene., 30, 588, 10.1038/onc.2010.442 · DOI
  27. Uchida, 2005, Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation, EMBO J., 24, 160, 10.1038/sj.emboj.7600486 · DOI · Paper page
  28. Bhattacharya, 2014, HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator, FEBS J., 281, 3061, 10.1111/febs.12843 · DOI · Paper page
  29. Granieri, 2022, Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors, Cell Rep., 40, 10.1016/j.celrep.2022.111396 · DOI
  30. Huang, 2011, Role of deubiquitylase HAUSP in stem cell maintenance, Cell Cycle, 10, 1182, 10.4161/cc.10.8.15260 · DOI
  31. Nicklas, 2019, A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7 balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification, Cell Death Differ., 26, 728, 10.1038/s41418-018-0144-1 · DOI
  32. Hillje, 2011, Neural stem cells maintain their stemness through protein kinase C ζ-mediated inhibition of TRIM32, Stem Cells, 29, 1437, 10.1002/stem.687 · DOI
  33. Bhattacharya, 2015, HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP, Cell Oncol (Dordr), 38, 265, 10.1007/s13402-015-0228-6 · DOI · Paper page
  34. Welcker, 2004, The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation, Proc. Natl. Acad. Sci. U. S. A., 101, 9085, 10.1073/pnas.0402770101 · DOI · Paper page
  35. Brockmann, 2016, Small molecule inhibitors of Aurora-a induce proteasomal degradation of N-Myc in childhood neuroblastoma, Cancer Cell, 30, 357, 10.1016/j.ccell.2016.07.002 · DOI
  36. Otto, 2009, Stabilization of N-Myc is a critical function of Aurora a in human neuroblastoma, Cancer Cell, 15, 67, 10.1016/j.ccr.2008.12.005 · DOI · Paper page
  37. Tavana, 2016, HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma, Nat. Med., 22, 1180, 10.1038/nm.4180 · DOI · Paper page
  38. Carrà, 2017, Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones, Oncotarget., 8, 35508, 10.18632/oncotarget.16348 · DOI · Paper page
  39. Zou, 2015, miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation, Oncotarget., 6, 1276, 10.18632/oncotarget.2626 · DOI
  40. Lebrun, 2012, The dual role of TGFβ in human cancer: from tumor suppression to cancer metastasis, ISRN Mol. Biol., 2012
  41. Huang, 2021, USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer, Cell Death Dis., 12, 880, 10.1038/s41419-021-04176-8 · DOI
  42. Rodriguez, 2018, PHD3 regulates p53 protein stability by Hydroxylating Proline 359, Cell Rep., 24, 1316, 10.1016/j.celrep.2018.06.108 · DOI · Paper page
  43. Tang, 2006, Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis, Mol. Cell, 24, 827, 10.1016/j.molcel.2006.11.021 · DOI · Paper page
  44. Kim, 2011, DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis, Mol. Cell, 44, 797, 10.1016/j.molcel.2011.09.023 · DOI
  45. Zhao, 2003, Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis, Cancer., 98, 18, 10.1002/cncr.11482 · doi:10.1002/cncr.11482
  46. Dihge, 2008, Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer, Breast Cancer Res. Treat., 109, 255, 10.1007/s10549-007-9645-1 · doi:10.1007/s10549-007-9645-1
  47. Yi, 2013, SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization, Genes Dev., 27, 274, 10.1101/gad.203760.112 · DOI · Paper page
  48. Levine, 2008, Autophagy in the pathogenesis of disease, Cell., 132, 27, 10.1016/j.cell.2007.12.018 · DOI · Paper page
  49. Mizushima, 2007, Autophagy: process and function, Genes Dev., 21, 2861, 10.1101/gad.1599207 · DOI · Paper page
  50. Zhang, 2020, USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway, Proc. Natl. Acad. Sci. U. S. A., 117, 28114, 10.1073/pnas.2014349117 · DOI · Paper page
  51. Xia, 2020, NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma, Mol. Oncol., 14, 763, 10.1002/1878-0261.12641 · DOI
  52. Fan, 2013, USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis, Cell Death Dis., 4, 10.1038/cddis.2013.400 · DOI · Paper page
  53. White, 2009, The double-edged sword of autophagy modulation in cancer, Clin. Cancer Res., 15, 5308, 10.1158/1078-0432.CCR-07-5023 · DOI · Paper page
  54. Lu, 2008, The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells, J. Clin. Invest., 118, 3917
  55. Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence, Aging (Albany NY), 8, 3, 10.18632/aging.100871 · DOI · Paper page
  56. Zemp, 2014, The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7, J. Biol. Chem., 289, 28595, 10.1074/jbc.M114.596056 · DOI · Paper page
  57. Claude, 2019, Specific death of ALT cells through TSPYL5 depletion, Mol. Cell. Oncol., 6
  58. Olive, 2009, Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science., 324, 1457, 10.1126/science.1171362 · DOI · Paper page
  59. Zee, 2010, Imaging angiogenesis of genitourinary tumors, Nat. Rev. Urol., 7, 69, 10.1038/nrurol.2009.262 · DOI
  60. Baeriswyl, 2009, The angiogenic switch in carcinogenesis, Semin. Cancer Biol., 19, 329, 10.1016/j.semcancer.2009.05.003 · DOI · Paper page
  61. Wu, 2022, Organ defects of the Usp7K444R mutant mouse strain indicate the essential role of K63-polyubiquitinated Usp7 in organ formation, Biom. J., S2319-4170
  62. Li, 2021, Lnc-RP11-536K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids, J. Exp. Clin. Cancer Res., 40, 348, 10.1186/s13046-021-02143-x · DOI
  63. Liu, 2015, Hypoxia-inducible factor-1α and Wnt/β-catenin signaling pathways promote the invasion of hypoxic gastric cancer cells, Mol. Med. Rep., 12, 3365, 10.3892/mmr.2015.3812 · DOI
  64. Liu, 2021, HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation, Proc. Natl. Acad. Sci. U. S. A., 118, 10.1073/pnas.2109144118 · DOI
  65. Novellasdemunt, 2017, USP7 is a tumor-specific WNT activator for APC-mutated colorectal cancer by mediating β-catenin Deubiquitination, Cell Rep., 21, 612, 10.1016/j.celrep.2017.09.072 · DOI · Paper page
  66. Lu, 2010, Regulation of tumor angiogenesis by EZH2, Cancer Cell, 18, 185, 10.1016/j.ccr.2010.06.016 · DOI · Paper page
  67. Lee, 2020, USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells, Genet. Mol. Biol., 43, 10.1590/1678-4685-gmb-2019-0338 · DOI
  68. Li, 2021, Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis, Mol. Ther. Oncolytics, 20, 583, 10.1016/j.omto.2020.12.008 · DOI
  69. Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021 · DOI · Paper page
  70. Pàez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027 · DOI · Paper page
  71. Yilmaz, 2009, EMT, the cytoskeleton, and cancer cell invasion, Cancer Metastasis Rev., 28, 15, 10.1007/s10555-008-9169-0 · DOI · Paper page
  72. Dihlmann, 2005, Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics, Int. J. Cancer, 113, 515, 10.1002/ijc.20609 · DOI · Paper page
  73. Han, 2012, MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK, CNS Neurosci. Ther., 18, 573, 10.1111/j.1755-5949.2012.00344.x · DOI · Paper page
  74. Basu, 2022, Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: shifting gears at the molecular level. Biochimica et Biophysica Acta (BBA) - molecular, Cell Res., 1869
  75. Zhang, 2016, Expression of USP7 and MARCH7 is correlated with poor prognosis in epithelial ovarian cancer, Tohoku J. Exp. Med., 239, 165, 10.1620/tjem.239.165 · DOI · Paper page
  76. Nathan, 2008, The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X, Traffic., 9, 1130, 10.1111/j.1600-0854.2008.00747.x · DOI · Paper page
  77. Ma, 2014, The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin, Mol. Cell. Biol., 34, 4355, 10.1128/MCB.00731-14 · DOI · Paper page
  78. Xiang, 2021, Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo, J. Cell. Mol. Med., 25, 9228, 10.1111/jcmm.16834 · DOI
  79. An, 2017, USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth, Biochem. Pharmacol., 131, 29, 10.1016/j.bcp.2017.02.011 · DOI
  80. Zeng, 2019, Ubiquitin-specific protease 7 promotes osteosarcoma cell metastasis by inducing epithelial-mesenchymal transition, Oncol. Rep., 41, 543
  81. Wang, 2010, The role of notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness, Curr. Drug Targets, 11, 745, 10.2174/138945010791170860 · DOI · Paper page
  82. Jin, 2019, USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell Leukemia, Clin. Cancer Res., 25, 222, 10.1158/1078-0432.CCR-18-1740 · DOI
  83. Kubaichuk, 2019, Involvement of E3 ligases and Deubiquitinases in the control of HIF-α subunit abundance, Cells., 8, E598, 10.3390/cells8060598 · DOI
  84. Chen, 2021, Diverse roles of FOXO family members in gastric cancer, World J. Gastrointest. Oncol., 13, 1367, 10.4251/wjgo.v13.i10.1367 · DOI
  85. Jiramongkol, 2020, FOXO transcription factor family in cancer and metastasis, Cancer Metastasis Rev., 39, 681, 10.1007/s10555-020-09883-w · DOI · Paper page
  86. Dansen, 2008, Unravelling the tumor-suppressive functions of FOXO proteins, Trends Cell Biol., 18, 421, 10.1016/j.tcb.2008.07.004 · DOI · Paper page
  87. Kim, 2018, Role of Forkhead box class O proteins in cancer progression and metastasis, Semin. Cancer Biol., 50, 142, 10.1016/j.semcancer.2017.07.007 · DOI · Paper page
  88. van der Horst, 2006, FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP, Nat. Cell Biol., 8, 1064, 10.1038/ncb1469 · DOI · Paper page
  89. Brenkman, 2008, Mdm2 induces mono-ubiquitination of FOXO4, PLoS One, 3, 10.1371/journal.pone.0002819 · DOI · Paper page
  90. Wang, 2012, Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation, Oncogene., 31, 1546, 10.1038/onc.2011.347 · DOI · Paper page
  91. Lei, 2019, EZH2 regulates protein stability via recruiting USP7 to mediate neuronal gene expression in cancer cells, Front. Genet., 10, 422, 10.3389/fgene.2019.00422 · DOI
  92. Gagarina, 2020, Structural basis of the interaction between ubiquitin specific protease 7 and enhancer of Zeste homolog 2, J. Mol. Biol., 432, 897, 10.1016/j.jmb.2019.12.026 · DOI
  93. Duan, 2022, EZH2-CCF-cGAS Axis promotes breast cancer metastasis, Int. J. Mol. Sci., 23, 1788, 10.3390/ijms23031788 · DOI
  94. Wang, 2015, The positive feedback between snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer, Oncotarget., 6, 27427, 10.18632/oncotarget.4861 · DOI
  95. Tiwari, 2013, Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming, Cancer Cell, 23, 768, 10.1016/j.ccr.2013.04.020 · DOI · Paper page
  96. Yi, 2016, Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway, Oncol. Rep., 36, 2935, 10.3892/or.2016.5099 · DOI · Paper page
  97. 2020, Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer, EMBO Rep., 21
  98. Tauriello, 2010, The various roles of ubiquitin in Wnt pathway regulation, Cell Cycle, 9, 3700, 10.4161/cc.9.18.13204 · DOI · Paper page
  99. Ji, 2019, USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin, Nat. Commun., 10, 4184, 10.1038/s41467-019-12143-3 · DOI · Paper page
  100. Jeggo, 2016, DNA repair, genome stability and cancer: a historical perspective, Nat. Rev. Cancer, 16, 35, 10.1038/nrc.2015.4 · DOI · Paper page
  101. He, 2014, Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis, J. Biol. Chem., 289, 27278, 10.1074/jbc.M114.589812 · DOI · Paper page
  102. Coleman, 2011, The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection, J. Biol. Chem., 286, 13669, 10.1074/jbc.M110.213728 · DOI · Paper page
  103. Hu, 2011, RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci, Genes Dev., 25, 685, 10.1101/gad.2011011 · DOI · Paper page
  104. Zimmermann, 2013, 53BP1 regulates DSB repair using Rif1 to control 5′ end resection, Science., 339, 700, 10.1126/science.1231573 · DOI · Paper page
  105. Poulsen, 2012, Human RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-strand breaks, J. Cell Biol., 197, 189, 10.1083/jcb.201109100 · DOI · Paper page
  106. Bunting, 2010, 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks, Cell., 141, 243, 10.1016/j.cell.2010.03.012 · DOI · Paper page
  107. Smith, 2010, The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer, Adv. Cancer Res., 108, 73, 10.1016/B978-0-12-380888-2.00003-0 · DOI · Paper page
  108. Boiteux, 2013, DNA repair mechanisms and the bypass of DNA damage in Saccharomyces cerevisiae, Genetics., 193, 1025, 10.1534/genetics.112.145219 · DOI · Paper page
  109. Marians, 2018, Lesion bypass and the reactivation of stalled replication forks, Annu. Rev. Biochem., 87, 217, 10.1146/annurev-biochem-062917-011921 · DOI · Paper page
  110. Hoege, 2002, RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO, Nature., 419, 135, 10.1038/nature00991 · DOI · Paper page
  111. Schwertman, 2012, UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair, Nat. Genet., 44, 598, 10.1038/ng.2230 · DOI · Paper page
  112. Fang, 2000, Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53, J. Biol. Chem., 275, 8945, 10.1074/jbc.275.12.8945 · DOI · Paper page
  113. Stad, 2001, Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms, EMBO Rep., 2, 1029, 10.1093/embo-reports/kve227 · DOI · Paper page
  114. Tang, 2006, Critical role for Daxx in regulating Mdm2, Nat. Cell Biol., 8, 855, 10.1038/ncb1442 · DOI · Paper page
  115. Tang, 2010, Daxx is reciprocally regulated by Mdm2 and Hausp, Biochem. Biophys. Res. Commun., 393, 542, 10.1016/j.bbrc.2010.02.051 · DOI · Paper page
  116. Song, 2008, The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex, EMBO J., 27, 1863, 10.1038/emboj.2008.115 · DOI
  117. Zhang, 2014, ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53, Nat. Commun., 5, 5059, 10.1038/ncomms6059 · DOI · Paper page
  118. Shen, 2018, TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation, Cell Death Dis., 9, 542, 10.1038/s41419-018-0589-7 · DOI
  119. Macheret, 2015, DNA replication stress as a Hallmark of cancer, Annu. Rev. Pathol.: Mech. Dis., 10, 425, 10.1146/annurev-pathol-012414-040424 · DOI · Paper page
  120. McGarry, 1998, Geminin, an inhibitor of DNA replication, is degraded during mitosis, Cell., 93, 1043, 10.1016/S0092-8674(00)81209-X · DOI · Paper page
  121. Lecona, 2016, A SUMO and ubiquitin code coordinates protein traffic at replication factories, Bioessays., 38, 1209, 10.1002/bies.201600129 · DOI
  122. Franz, 2021, USP7 and VCPFAF1 define the SUMO/ubiquitin landscape at the DNA replication fork, Cell Rep., 37, 10.1016/j.celrep.2021.109819 · DOI
  123. Ma, 2013, Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells, Immunity., 38, 729, 10.1016/j.immuni.2013.03.003 · DOI · Paper page
  124. Zhao, 2021, Inflammation and tumor progression: signaling pathways and targeted intervention, Signal Transduct Target Ther., 6, 263, 10.1038/s41392-021-00658-5 · DOI · Paper page
  125. Hayden, 2008, Shared principles in NF-kappaB signaling, Cell., 132, 344, 10.1016/j.cell.2008.01.020 · DOI · Paper page
  126. Mao, 2009, GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA, Genes Dev., 23, 849, 10.1101/gad.1748409 · DOI · Paper page
  127. Ryo, 2003, Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA, Mol. Cell, 12, 1413, 10.1016/S1097-2765(03)00490-8 · DOI · Paper page
  128. Tanaka, 2007, PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit, Nat. Immunol., 8, 584, 10.1038/ni1464 · DOI · Paper page
  129. Maine, 2007, COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase, EMBO J., 26, 436, 10.1038/sj.emboj.7601489 · DOI · Paper page
  130. Carmody, 2007, Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade, Science., 317, 675, 10.1126/science.1142953 · DOI · Paper page
  131. Liu, 2017, Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression, Hepatology., 66, 1894, 10.1002/hep.29337 · DOI
  132. Gan, 2009, HSCARG inhibits activation of NF-kappaB by interacting with IkappaB kinase-beta, J. Cell Sci., 122, 4081, 10.1242/jcs.054007 · DOI
  133. Li, 2014, HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination, Cell Death Dis., 5, 10.1038/cddis.2014.197 · DOI
  134. Xia, 2019, Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis, Cancer Lett., 465, 118, 10.1016/j.canlet.2019.09.003 · DOI
  135. Lee, 2011, Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers, Mol. Cell, 43, 798, 10.1016/j.molcel.2011.08.011 · DOI · Paper page
  136. Su, 2021, Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis, Nucleic Acids Res., 49, 4421, 10.1093/nar/gkab209 · DOI
  137. Zhao, 2020, P22077 inhibits LPS-induced inflammatory response by promoting K48-linked ubiquitination and degradation of TRAF6, Aging (Albany NY), 12, 10969, 10.18632/aging.103309 · DOI
  138. O’Callaghan, 2015, Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer, Eur. Respir. J., 46, 1762, 10.1183/13993003.00176-2014 · DOI · Paper page
  139. Tu, 2017, Annexin A1 influences in breast cancer: controversies on contributions to tumour, host and immunoediting processes, Pharmacol. Res., 119, 278, 10.1016/j.phrs.2017.02.011 · DOI
  140. Powell, 2007, Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo, J. Immunol., 179, 4919, 10.4049/jimmunol.179.7.4919 · DOI · Paper page
  141. Sharma, 2011, Novel cancer immunotherapy agents with survival benefit: recent successes and next steps, Nat. Rev. Cancer, 11, 805, 10.1038/nrc3153 · DOI · Paper page
  142. Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy, Nat. Rev. Cancer, 12, 252, 10.1038/nrc3239 · DOI · Paper page
  143. Dranoff, 2005, CTLA-4 blockade: unveiling immune regulation, J. Clin. Oncol., 23, 662, 10.1200/JCO.2005.09.923 · DOI
  144. Fietta, 2009, Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer, Hum. Immunol., 70, 477, 10.1016/j.humimm.2009.03.012 · DOI
  145. van Loosdregt, 2013, Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity, Immunity., 39, 259, 10.1016/j.immuni.2013.05.018 · DOI · Paper page
  146. De Ceuninck, 2013, Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing, J. Cell Sci., 126, 3770
  147. Colombo, 2010, Synthesis and biological evaluation of 9-Oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes, ChemMedChem., 5, 552, 10.1002/cmdc.200900409 · DOI · Paper page
  148. Kim, 2017, Foxp3 is a key downstream regulator of p53-mediated cellular senescence, Oncogene., 36, 219, 10.1038/onc.2016.193 · DOI
  149. Wang, 2016, Ubiquitin-specific Protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity, EBioMedicine., 13, 99, 10.1016/j.ebiom.2016.10.018 · DOI · Paper page
  150. Wang, 2017, Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60, PLoS One, 12, 10.1371/journal.pone.0189744 · DOI · Paper page
  151. Khosravi, 2018, Induction of CD4+CD25+FOXP3+ regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation, Stem Cell Res Ther, 9, 273, 10.1186/s13287-018-0991-1 · DOI
  152. Fu, 2019, Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy, Onco. Targets Ther., 12, 609, 10.2147/OTT.S182806 · DOI
  153. Yang, 2020, The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation, EMBO Rep., 21, 10.15252/embr.202050308 · DOI
  154. Muthukumarana, 2006, Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance, Int. Immunopharmacol., 6, 1993, 10.1016/j.intimp.2006.09.015 · DOI
  155. Wang, 2020, Mouse double minute 2 homolog-mediated ubiquitination facilitates Forkhead box P3 stability and positively modulates human regulatory T cell function, Front. Immunol., 11, 1087, 10.3389/fimmu.2020.01087 · DOI
  156. Wang, 2021, Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing, Acta Pharm. Sin. B, 11, 694, 10.1016/j.apsb.2020.11.005 · DOI
  157. Dai, 2020, USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer, Theranostics., 10, 9332, 10.7150/thno.47137 · DOI · Paper page
  158. Chen, 2021, Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC, Mol. Cancer, 20, 144, 10.1186/s12943-021-01448-x · DOI · Paper page
  159. Henrique, 2020, Biological and physical approaches on the role of piplartine (piperlongumine) in cancer, Sci. Rep., 10
  160. Park, 2015, Annexin-1 regulated by HAUSP is essential for UV-induced damage response, Cell Death Dis., 6, 10.1038/cddis.2015.32 · DOI
  161. Warburg, 1956, On the origin of cancer cells, Science., 123, 309, 10.1126/science.123.3191.309 · DOI · Paper page
  162. Kim, 2021, Regulation of cancer metabolism by deubiquitinating enzymes: the Warburg effect, Int. J. Mol. Sci., 22, 6173, 10.3390/ijms22126173 · DOI
  163. Hall, 2014, USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy, Mol. Endocrinol., 28, 912, 10.1210/me.2013-1420 · DOI · Paper page
  164. Kiran, 2015, Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh Sirtuin!, Cell. Signal., 27, 673, 10.1016/j.cellsig.2014.11.026 · DOI
  165. Wu, 2018, Advances in cellular characterization of the Sirtuin isoform, SIRT7, Front. Endocrinol. (Lausanne), 9, 652, 10.3389/fendo.2018.00652 · DOI · Paper page
  166. Jiang, 2017, Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis, J. Biol. Chem., 292, 13296, 10.1074/jbc.M117.780130 · DOI · Paper page
  167. Georges, 2018, Identification and characterization of USP7 targets in cancer cells, Sci. Rep., 8, 15833, 10.1038/s41598-018-34197-x · DOI · Paper page
  168. Felle, 2011, The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1, Nucleic Acids Res., 39, 8355, 10.1093/nar/gkr528 · DOI · Paper page
  169. Qin, 2011, Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1, J. Cell. Biochem., 112, 439, 10.1002/jcb.22998 · DOI · Paper page
  170. Jenkins, 2005, Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth, Mol. Biol. Cell, 16, 5621, 10.1091/mbc.e05-03-0194 · DOI · Paper page
  171. Saha, 2022, USP7 targets XIAP for cancer progression: establishment of a p53-independent therapeutic avenue for glioma, Oncogene, 41, 5061, 10.1038/s41388-022-02486-5 · DOI
  172. Bushman, 2021, Proteomics-based identification of DUB substrates using selective inhibitors, Cell Chem. Biol., 28, 78, 10.1016/j.chembiol.2020.09.005 · DOI · Paper page
  173. Steger, 2021, Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale, Nat. Commun., 12, 5399, 10.1038/s41467-021-25454-1 · DOI · Paper page
  174. Tsukamoto, 2016, Search for inhibitors of the ubiquitin-proteasome system from natural sources for cancer therapy, Chem. Pharm. Bull. (Tokyo), 64, 112, 10.1248/cpb.c15-00768 · DOI
  175. Li, 2020, Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors, Eur. J. Med. Chem., 191, 10.1016/j.ejmech.2020.112107 · DOI · Paper page
  176. Altun, 2011, Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes, Chem. Biol., 18, 1401, 10.1016/j.chembiol.2011.08.018 · DOI · Paper page
  177. Chen, 2017, Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors, Bioorg. Med. Chem. Lett., 27, 845, 10.1016/j.bmcl.2017.01.018 · DOI
  178. Colland, 2009, Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells, Mol. Cancer Ther., 8, 2286, 10.1158/1535-7163.MCT-09-0097 · DOI · Paper page
  179. Ohol, 2020, Novel, selective inhibitors of USP7 uncover multiple mechanisms of antitumor activity in vitro and in vivo, Mol. Cancer Ther., 19, 1970, 10.1158/1535-7163.MCT-20-0184 · DOI
  180. Li, 2021, Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors, Eur. J. Med. Chem., 216, 10.1016/j.ejmech.2021.113291 · DOI
  181. Gavory, 2018, Discovery and characterization of highly potent and selective allosteric USP7 inhibitors, Nat. Chem. Biol., 14, 118, 10.1038/nchembio.2528 · DOI · Paper page
  182. Murgai, 2022, Targeting the deubiquitinase USP7 for degradation with PROTACs, Chem. Commun. (Camb.), 58, 8858, 10.1039/D2CC02094G · DOI
  183. Pei, 2022, Discovery of a potent and selective degrader for USP7, Angew. Chem. Int. Ed. Eng., 61
  184. Li, 2020, N-benzylpiperidinol derivatives as novel USP7 inhibitors: structure-activity relationships and X-ray crystallographic studies, Eur. J. Med. Chem., 199, 10.1016/j.ejmech.2020.112279 · DOI
  185. Yamaguchi, 2013, Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor, Bioorg. Med. Chem. Lett., 23, 3884, 10.1016/j.bmcl.2013.04.066 · DOI · Paper page
  186. Tanokashira, 2016, Petroquinones: trimeric and dimeric xestoquinone derivatives isolated from the marine sponge Petrosia alfiani, Tetrahedron., 72, 5530, 10.1016/j.tet.2016.07.045 · DOI
  187. Afifi, 2017, Sulawesins A–C, Furanosesterterpene Tetronic Acids That Inhibit USP7, from a Psammocinia sp. Marine Sponge, J. Nat. Prod., 80, 2045, 10.1021/acs.jnatprod.7b00184 · DOI

Cited by

See all 101

Metadata

Authors
Saha, G., Roy, S., Basu, M., & Ghosh, M. K.
Venue
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Publisher
Elsevier BV
Published
2023-05
Volume
1878
Issue
3
Pages
188903
ISSN
0304-419X
Cited by
101
References
56
Language
en
Funders
  • Department of Science and Technology, Ministry of Science and Technology, India (DST/NM/NT/2018/105)
  • Council of Scientific and Industrial Research, India (HCP-40, MLP-142)
  • Science and Engineering Research Board (EMR/2017/000992/HS)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.